Wordt geladen...
Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
The waiver of the in vivo demonstration of bioequivalence (biowaiver) is an established tool in drug development and regulatory assessment. This study reviews the use of different biowaiver approaches in centralized applications for marketing authorization to the European Medicines Agency for generi...
Bewaard in:
| Gepubliceerd in: | Clin Transl Sci |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6742938/ https://ncbi.nlm.nih.gov/pubmed/31046182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12642 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|